October 07, 2022
Webinar
On behalf of CNS 2022, we are delighted and deeply honoured to welcome you all to the 12th International Conference on Central Nervous System scheduled to take place in Madrid, Spain in the month October 07, 2022.
CNS 2022 is one of the topmost leading neuroscience conferences in the world. Join the International Central Nervous System Conference to meet the elites in Neuroscience.
We welcome all the attendees to the CNS 2022 to discuss the theme, “Breakthroughs to Excellence in Neuroscience”.
CNS 2022 provides a unique platform for neurologists, neuroscientists, neuropsychiatrists, neurosurgeons, researchers, technicians, students, and other related allied health professionals. to share experiences and knowledge in one of the most popular cities in Spain.
We look forward to welcoming you to Madrid, Spain for CNS 2022!
CNS 2022 is an annual meeting of distinguished international professionals in the field of neuroscience, neurologists and other well-being experts along with the committee members, to discuss the fostering innovations in neuroscience.
The event will feature advanced research from every domain of neuroscience. The program furnishes poster presentations, workshops, exhibitions as well as lectures on cutting-edge research.
The attendees will have the opportunity to hear and discuss the exciting developments in our understanding of the Central Nervous System and strategies to treat neurological disorders and also will furnish great opportunity to interact with world-class professionals and colleagues from around the world
We henceforth look forward and cordially welcome you all to participate and make this event grandeur.
Target Audience:
Neurologists, Neurosurgeons, Scientists, Researchers, Scholars, Academic scientists, Diagnostic Laboratory Professionals, Students and other allied Health professionals.
Conference Highlights:
For Researchers and Faculty Members:
For Universities, Associations & Societies:
For Students:
For Business Delegates:
For Product Manufacturers:
The scientific program of CNS 2022 encompasses oral presentations, poster presentations,workshops, symphosia, young research forums, and e-posters for the deliberation of recent advances through the topics below.
We would like to thank all our amazing keynote speakers, plenary speakers, delegates who made the 11th International Conference on Central Nervous System an extraordinary event.
The Editorial Board Members of supporting International Journals, and important academic scientists, neurologists, research scholars, researchers, students and experts within the domains of Neurology, Neuromodulation and Neurosurgery gave magnanimous responses, participated with enthusiasm and which made CNS 2022 a grand success.
Pulsus conferences executed the virtual event of CNS 2022 successfully on April 27, 2022.
The conference was honoured by the active participation of young and brilliant academics, business delegates from more than 20 countries, and everyone contributed to the triumph of the conference. Various presentations on the latest research in the field of Central Nervous System were highlighted at the conference. CNS 2022 had a slew of international speakers who shared their knowledge and conferred on the cutting-edge topics of Central Nervous System.
CNS 2022 had efficient presentations around the theme “Unveiling the advances of Central Nervous System”.
Honourable Speakers
After the successful execution of CNS 2022, we are glad to announce the 12th International Conference on Central Nervous System scheduled to take place during October 07, 2022 in Madrid, Spain.
The e-book of the 11th International Conference on Central Nervous System is available at https://online.fliphtml5.com/jrpwu/cgzw/
The market for therapies for the central nervous system (CNS) was estimated at USD 95,573.08 million in 2021. By 2027, it is anticipated to have grown to USD 142,033.02 million, registering a CAGR of 7.41%. (2022-2027). Healthcare services focused all of their resources on treating COVID-19 disease patients as a result of the rising COVID-19 cases around the world. COVID-19 has been found to affect the central and peripheral nervous systems and their significant effects on the respiratory system.
Hypoxia or anoxia harms the nervous system, is one of the most severe effects in COVID-19 patients, especially in those with significantly low O2 saturation. Encephalopathy was the first symptom for thirty individuals. Additionally, during the pandemic phase, clinical trials on repurposing antidepressants for COVID-19 have risen, which is anticipated to impact the market for CNS medicines significantly. On the market, this research is expected to have a significant impact.
The primary factor driving the growth of the CNS therapies market is the increase in the number of people suffering from CNS diseases. According to the Alzheimer's Association publication Alzheimer's Disease Facts and Figures 2022, Alzheimer's is the sixth most prevalent cause of death in the country and is more common in persons over 65. According to the cited source, an estimated 6.5 million Americans aged 65 and older will have Alzheimer's disease in 2022.The publication stated above also predicted that by 2050, 12.7 million persons aged 65 and older would have Alzheimer's disease. It is predicted that this number will rise quickly in the upcoming years. As a result, the high occurrence of disease necessitates the availability of drugs and therapeutics to treat fuels market expansion.
Metrics
